| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/25/1999 | WO1999050298A9 GFRα-X, A NOVEL GLIAL-DERIVED NEUROTROPHIC FACTOR RECEPTOR AND USES THEREFOR |
| 11/25/1999 | WO1999048523A3 Antagonists of the inflammatory mediator oncostatin m (osm) |
| 11/25/1999 | WO1999047925A3 Methods and compositions for diagnosis of rheumatoid arthritis |
| 11/25/1999 | WO1999047689A3 Inhibitors of apoptosis proteins in plants |
| 11/25/1999 | WO1999047679A3 Genetic engineering salt tolerance in crop plants |
| 11/25/1999 | WO1999047656A3 Nucleic acid binding proteins |
| 11/25/1999 | WO1999047158A3 Therapeutic chemokine receptor antagonists |
| 11/25/1999 | WO1999046592A9 Regulation of the cell cycle by sterols |
| 11/25/1999 | WO1999045957A3 Combined vaccine compositions |
| 11/25/1999 | WO1999045128A8 Chimeric proteins with cell-targeting specificity and apoptosis-dinducing activities |
| 11/25/1999 | WO1999043835A3 Methods for producing a polypeptide in a bacillus cell |
| 11/25/1999 | WO1999043832A3 Human proteinase molecules |
| 11/25/1999 | WO1999043808A8 Human c-maf compositions and methods of use thereof |
| 11/25/1999 | WO1999042834A3 Treating cancer |
| 11/25/1999 | WO1999041390A3 Expression vector for the production of dead proteins |
| 11/25/1999 | WO1999040199A3 A novel fungal protein critical for expression of fungal proteins |
| 11/25/1999 | WO1999038976A3 Human growth factor homologs |
| 11/25/1999 | WO1999032627A3 The protein tyrosine kinase substrate lat and its use in the identification of (ant)agonists of the kinase |
| 11/25/1999 | WO1999029902A8 Method for creating polynucleotide and polypeptide sequences |
| 11/25/1999 | WO1999005527A3 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 11/25/1999 | DE19806803A1 Transporter für Saccharid-gekoppelte Zytostatika in Tumorzellen Transportation for saccharide-linked cytotoxic agents in tumor cells |
| 11/25/1999 | CA2690399A1 Il-6 antagonist peptides |
| 11/25/1999 | CA2341350A1 Transgenic animals produced by homologous sequence targeting |
| 11/25/1999 | CA2333921A1 Verotoxin b subunit for immunization |
| 11/25/1999 | CA2333144A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases |
| 11/25/1999 | CA2332639A1 Methods and compositions for producing viral particles |
| 11/25/1999 | CA2332507A1 Angiostatin receptor |
| 11/25/1999 | CA2332338A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 11/25/1999 | CA2332277A1 Labelled glutamine and lysine analogues |
| 11/25/1999 | CA2332150A1 Mechanical stress induced genes, expression products therefrom, and uses thereof |
| 11/25/1999 | CA2331917A1 Novel method for gene cloning |
| 11/25/1999 | CA2329901A1 Assays, methods and means for modulating e2f activity |
| 11/25/1999 | CA2329868A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products |
| 11/25/1999 | CA2329153A1 Novel g-protein coupled receptor |
| 11/25/1999 | CA2329139A1 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof |
| 11/25/1999 | CA2328605A1 Protein z-dependent protease inhibitor |
| 11/25/1999 | CA2328603A1 Novel compositions comprising interleukin-18 and a chemotherapeutic agent |
| 11/25/1999 | CA2328597A1 Display of viral proteins as ligands for cell-surface receptor |
| 11/25/1999 | CA2328529A1 Immunoregulator from a human chorionic gonadotropin preparation |
| 11/25/1999 | CA2328527A1 Secreted proteins |
| 11/25/1999 | CA2328501A1 Prevention and treatment of hypergastrinemia |
| 11/25/1999 | CA2328496A1 Il-17 homologous polypeptides and therapeutic uses thereof |
| 11/25/1999 | CA2328489A1 Secreted proteins and polynucleotides encoding them |
| 11/25/1999 | CA2328486A1 Osteoporosis treatment |
| 11/25/1999 | CA2328386A1 Insect control gene dsf and methods of use |
| 11/25/1999 | CA2328144A1 Multivalent t cell receptor complexes |
| 11/25/1999 | CA2327314A1 Soluble t cell receptor |
| 11/25/1999 | CA2323575A1 Methods and compounds for modulating nuclear receptor coactivator binding |
| 11/25/1999 | CA2323316A1 Soybean gene promoters |
| 11/25/1999 | CA2323312A1 Genes and methods for control of nematodes in plants |
| 11/24/1999 | EP0959135A1 Display of viral proteins and targeted delivery to cellular receptor |
| 11/24/1999 | EP0959132A2 Nucleic acid encoding receptor type protein kinase |
| 11/24/1999 | EP0959131A2 Method for cloning and producing the AgeI restriction endonuclease in E. coli |
| 11/24/1999 | EP0959129A1 Drugs for treating exocrine gland disorders and transgenic mice to be used for screening the same |
| 11/24/1999 | EP0958834A1 Peptide immunotherapeutic agent |
| 11/24/1999 | EP0958501A1 Method for screening substances with therapeutic action in the treatment of transmissible subacute spongiform encephalopathy |
| 11/24/1999 | EP0958382A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 11/24/1999 | EP0958377A1 Process for identification of genes encoding proteins having cell proliferation-promoting activity |
| 11/24/1999 | EP0958376A1 Prolactin receptor gene as a genetic marker for increased litter size in pigs |
| 11/24/1999 | EP0958374A1 T1 receptor-like ligand i |
| 11/24/1999 | EP0958373A1 Vaccines |
| 11/24/1999 | EP0958371A2 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 11/24/1999 | EP0958366A1 Human chemokine beta-13 |
| 11/24/1999 | EP0958365A1 Granulocyte chemotactic protein 2 variant |
| 11/24/1999 | EP0958364A1 Immunotherapy and improved vaccines |
| 11/24/1999 | EP0958363A1 Human regulator of g-protein signaling - (hrgs) |
| 11/24/1999 | EP0958362A1 Isolation and use of motoneuronotrophic factors |
| 11/24/1999 | EP0958361A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 11/24/1999 | EP0958360A2 Secreted proteins and polynucleotides encoding them |
| 11/24/1999 | EP0958359A1 Protein inhibitor of neuronal nitric oxide synthase |
| 11/24/1999 | EP0958358A1 Method for preparing a plasmid dna |
| 11/24/1999 | EP0958357A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 11/24/1999 | EP0958305A2 Inhibitions of the interaction between p53 and mdm2 |
| 11/24/1999 | EP0958304A1 Nucleotide sequence encoding the cd33-like protein |
| 11/24/1999 | EP0957943A1 Matrix-free osteogenic devices, implants and methods of use thereof |
| 11/24/1999 | EP0957937A1 VACCINES, ANTIBODIES, PROTEINS, GLYCOPROTEINS, DNAS AND RNAS FOR PROPHYLAXIS AND TREATMENT OF $i(CRYPTOSPORIDIUM PARVUM) INFECTIONS |
| 11/24/1999 | EP0957936A1 Formulations of recombinant papillomavirus vaccines |
| 11/24/1999 | EP0957935A1 Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof |
| 11/24/1999 | EP0957934A1 Targeting antigens to the mhc class i processing pathway with anthrax toxin fusion protein |
| 11/24/1999 | EP0957929A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 11/24/1999 | EP0957902A1 System for genetically treating cardiac conduction disturbances |
| 11/24/1999 | EP0957672A1 Hypersensitive response induced resistance in plants by seed treatment |
| 11/24/1999 | EP0845045A4 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 11/24/1999 | EP0833653A4 Serum immunoregulatory polypeptides and uses therefor |
| 11/24/1999 | EP0797663A4 Sox-9 gene and protein and use in the regeneration of bone or cartilage |
| 11/24/1999 | EP0753060A4 Conserved t-cell receptor sequences |
| 11/24/1999 | EP0730470A4 Improved interferon polymer conjugates |
| 11/24/1999 | CN1236394A Herbicide resistant plants |
| 11/24/1999 | CN1236392A Phsopholipase D and DNA sequences |
| 11/24/1999 | CN1236391A Method for producing recombinants intended for use in a complete malaria antigene gp 190/MSP1 |
| 11/24/1999 | CN1236390A Angiogenic factor and use thereof of treating cardiovascular disease |
| 11/24/1999 | CN1236370A Chemically modified polypeptides |
| 11/24/1999 | CN1236320A Therapeutic uses of BPI protein products for human meningococcemia |
| 11/24/1999 | CN1236010A Method for giving resistance to weed control compounds to plants |
| 11/24/1999 | CN1235981A Express and purification of human serum albumin in Pichia |
| 11/24/1999 | CN1235980A Human calcitonin analogue |
| 11/24/1999 | CN1235979A Design of cell factor or growth factor analogue polymer and its use |
| 11/24/1999 | CN1235978A Protein participating in activation of nitrile hydratase and gene encoding the same |
| 11/24/1999 | CN1046775C Dye transfer inhibition |
| 11/24/1999 | CN1046635C Composition and mether using nitrooxides to avoid oxygen toxicity |